AI assistant
Imunon, Inc. — Director's Dealing 2024
Oct 31, 2024
35124_dirs_2024-10-31_0b9c5b85-6ee4-46df-a6fa-fe7424d07fd4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2024-09-06
Reporting Person: Lindborg Stacy (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-06 | Restricted Stock Units | $ | A | 25000 | Acquired | Common Stock (25000) | Direct |
Footnotes
F1: This amendment reports a new transaction that was inadvertently omitted from the Form 4 filed on September 10, 2024 by the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of Imunon, Inc.'s common stock.
F2: On September 6, 2024, Ms. Lindborg received restricted stock units representing 25,000 shares subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.